P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971124.18635.63 |
| _version_ | 1797280003738566656 |
|---|---|
| author | Lucia Masarova Srdan Verstovsek Francesca Palandri Ruben Mesa Claire Harrison Balazs Dobi Boris Gorsh Zhaohui Wang Catherine Ellis Dwaipayan Patnaik Venediktos Kapetanakis |
| author_facet | Lucia Masarova Srdan Verstovsek Francesca Palandri Ruben Mesa Claire Harrison Balazs Dobi Boris Gorsh Zhaohui Wang Catherine Ellis Dwaipayan Patnaik Venediktos Kapetanakis |
| author_sort | Lucia Masarova |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:34:57Z |
| format | Article |
| id | doaj.art-ec5744bc5fec476f84c911eefb1673d5 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:34:57Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-ec5744bc5fec476f84c911eefb1673d52024-03-03T10:04:26ZengWileyHemaSphere2572-92412023-08-017e186356310.1097/01.HS9.0000971124.18635.63202308003-00955P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSISLucia Masarova0Srdan Verstovsek1Francesca Palandri2Ruben Mesa3Claire Harrison4Balazs Dobi5Boris Gorsh6Zhaohui Wang7Catherine Ellis8Dwaipayan Patnaik9Venediktos Kapetanakis101 MD Anderson Cancer Center1 MD Anderson Cancer Center2 IRCCS Azienda Ospedaliero-Universitaria di Bologna3 Wake Health4 Guy’s and St Thomas’ NHS Foundation Trust5 Evidera6 GSK plc6 GSK plc6 GSK plc6 GSK plc5 Eviderahttp://journals.lww.com/10.1097/01.HS9.0000971124.18635.63 |
| spellingShingle | Lucia Masarova Srdan Verstovsek Francesca Palandri Ruben Mesa Claire Harrison Balazs Dobi Boris Gorsh Zhaohui Wang Catherine Ellis Dwaipayan Patnaik Venediktos Kapetanakis P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS HemaSphere |
| title | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_full | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_fullStr | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_full_unstemmed | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_short | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_sort | p1057 indirect treatment comparisons of momelotinib vs pacritinib safety and anemia outcomes in patients with myelofibrosis |
| url | http://journals.lww.com/10.1097/01.HS9.0000971124.18635.63 |
| work_keys_str_mv | AT luciamasarova p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT srdanverstovsek p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT francescapalandri p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT rubenmesa p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT claireharrison p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT balazsdobi p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT borisgorsh p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT zhaohuiwang p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT catherineellis p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT dwaipayanpatnaik p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT venediktoskapetanakis p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis |